BioCardia, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioCardia, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • BioCardia, Inc. Return On Equity for the quarter ending June 30, 2024 was 527 %.
  • BioCardia, Inc. annual Return On Equity for 2023 was -3.64K %, a 1664% decline from 2022.
  • BioCardia, Inc. annual Return On Equity for 2022 was -206 %, a 137% decline from 2021.
  • BioCardia, Inc. annual Return On Equity for 2021 was -87 %, a 57.5% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -3.64K -3.43K -1664% Jan 1, 2023 Dec 31, 2023
2022 -206 -119 -137% Jan 1, 2022 Dec 31, 2022
2021 -87 +118 +57.5% Jan 1, 2021 Dec 31, 2021
2020 -205 +752 +78.6% Jan 1, 2020 Dec 31, 2020
2019 -957 -687 -254% Jan 1, 2019 Dec 31, 2019
2018 -270 -187 -226% Jan 1, 2018 Dec 31, 2018
2017 -83 -22.1 -36.2% Jan 1, 2017 Dec 31, 2017
2016 -60.9 +10.3 +14.4% Jan 1, 2016 Dec 31, 2016
2015 -71.2 -38 -114% Jan 1, 2015 Dec 31, 2015
2014 -33.2 -33.3 -23311% Jan 1, 2014 Dec 31, 2014
2013 0.14 -2.19 -93.8% Jan 1, 2013 Dec 31, 2013
2012 2.33 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.